ArticleCancer immunology, immunotherapy : CII2019

Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.

Vylyny Chat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.